Sector: Pharmaceuticals & Biotechnology
|Small Cap
Trident Lifeline Ltd.
₹254
₹249.90
₹259.80
Data is not available
Markets Today
Historical Performance
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 31.97 | 23.67 | 27.44 | 18.82 | 20.89 |
| Operating Expense | 25.23 | 17.39 | 21.06 | 13.89 | 16.01 |
| Operating Profit | 6.74 | 6.28 | 6.38 | 4.93 | 4.88 |
| Depreciation | 0.04 | 0.71 | 0.59 | 0.51 | 0.67 |
| Interest | 0.38 | 0.54 | 0.42 | 0.33 | 0.41 |
| Tax | 2.29 | 1.91 | 1.54 | 1.15 | 1.80 |
| Net Profit | 5.66 | 4.01 | 4.94 | 3.48 | 3.62 |
₹254.00
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 63 | 63 | 63 | 63.1 | 64.1 | 62.8 |
| FII | 6.1 | 6.6 | 7.2 | 7.7 | 7 | 7.2 |
| DII | 0 | 0.1 | 0.4 | 0.4 | 0.4 | 0.3 |
| Public | 30.9 | 30.2 | 29.4 | 28.8 | 28.5 | 29.6 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 18 K | 29.4 K | 61.22% |
| Week | 26.76 K | 38.4 K | 69.69% |
| 1 Month | 25.71 K | 37 K | 69.50% |
| 6 Month | 18.85 K | 24.42 K | 77.19% |
Undervalued Growth Stocks
Jim Slater's Zulu Principle (Discover Growth Stocks)
Mid-range Performer (DVM)
Rising Net Cash Flow and Cash from Operating activity
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with reducing Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹46.26 | ₹492.90 | ₹219.30 | ₹252.10 | ₹38.27 | ₹6.40 |
| % Change | -4.99% | 1.27% | 4.95% | -4.14% | 4.99% | -2.14% |
| Revenue TTM (₹ Cr) | - | - | - | - | ₹0.54 | ₹83.60 |
| Net Profit TTM (₹ Cr) | - | - | - | - | ₹-0.24 | ₹-34.95 |
| PE TTM | 18.30 | - | 23.60 | 37.60 | -89.20 | -1.50 |
| 1 Year Return | 22.61 | 679.78 | 551 | |||
| ROCE | - | 28.91 | - | - | - | -5.63 |
Curis Lifesciences Ltd.
₹ 122.00
-1.61%
Aptus Pharma Ltd.
₹ 179.50
-1.37%
Amanta Healthcare Ltd.
₹ 131.01
+0.71%
Anlon Healthcare Ltd.
₹ 13.79
-0.86%
Medistep Healthcare Ltd.
₹ 19.65
+7.67%
Patel Chem Specialities Ltd.
₹ 87.00
-4.05%
Asston Pharmaceuticals Ltd.
₹ 72.80
+0.00%
Influx Healthtech Ltd.
₹ 236.10
-5.48%
Medicamen Organics Ltd.
₹ 24.00
-1.84%
Amrutanjan Health Care Ltd.
₹ 559.75
+0.46%
Astonea Labs Ltd.
₹ 231.00
+1.76%
Amwill Health Care Ltd.
₹ 32.38
+4.96%
Innova Captab Ltd.
₹ 852.80
+0.53%
Valiant Laboratories Ltd.
₹ 78.00
+1.46%
Shelter Pharma Ltd.
₹ 30.63
-0.07%
Dipna Pharmachem Ltd.
₹ 7.47
-0.66%
Achyut Healthcare Ltd.
₹ 5.83
+2.64%
Sigachi Industries Ltd.
₹ 20.34
-0.05%
Windlas Biotech Ltd.
₹ 784.40
-0.70%
Vineet Laboratories Ltd.
₹ 35.00
-1.69%
Chandra Bhagat Pharma Ltd.
₹ 40.00
+5.26%
Solara Active Pharma Sciences Ltd.
₹ 556.00
+1.44%
By signing up I certify terms, conditions & privacy policy